Join
Live feed
·
INSIDERFilingvia Quantisnow
Viracta Therapeutics Inc. logo

SEC Form 4: Chevallard Daniel R. converted options into 6,888 shares and sold $5,092 worth of shares (3,512 units at $1.45), increasing direct ownership by 4% to 95,653 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VIRX (Viracta Therapeutics Inc.) and more on Quantisnow.